.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Moodys
Johnson and Johnson
AstraZeneca
Citi
Fish and Richardson
US Army
Baxter
Daiichi Sankyo
Teva

Generated: November 23, 2017

DrugPatentWatch Database Preview

Drug Master Files for: botulinum

« Back to Dashboard
DMF No. Status Type Submission Date Holder Subject
13863III11/25/1998UNIV WISCONSIN FOOD RESEARCH INSTITUTEPREPARATION OF BOTULINUM TOXINS A THROUGH G FOR MOUSE NEUTRALIZATION ASSAYS
21140AII12/17/2007LIST BIOLOGICAL LABORATORIES INCBotulinum Toxin A Pure Neurotoxin
27519III10/3/2001UNIV CHICAGO DEPT OTOLARYNGOLOGY HEAD AND NECK SURGERYBOTOX(R) (BOTULINUM TOXIN A) PURIFIED NEUROTOXIN COMPLEX
27520III1/13/1999UNIV TEXAS MEDICAL BRANCHBOTULINUM TOXIN
27517III4/25/2000COLORADO NEUROLOGICAL INSTITUTEBOTULINUM TOXIN B
27509III1/9/2004ALLERGAN INCBOTOX (R) (BOTULINUM TOXIN A) PURIFIED NEUROTOXIN COMPLEX
27360III4/10/2003BIOMEASURE INCBOTULINUM TOXIN A - HEMAGGLUTININ COMPLEX TREATMENT OF GLABELLAR LINES
27515III3/26/2003BIOMEASURE INCDYSPORT(R) (BOTULINUM TOXIN A-HEMAGGLUTININ COMPLEX)
27365III3/26/2003IPSEN LTDDYSPORT (BOTULINUM TOXIN A-HEMAGGLUTININ COMPLEX)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Chinese Patent Office
Argus Health
Teva
Baxter
Johnson and Johnson
Healthtrust
Deloitte
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot